Since our PBPK model is based on the physio(bio)logical process of PSMA binding/internalization/degradation [37], each related kinetic parameter for PSMA-positive organs (here: tumor, kidneys, and salivary gland) impacts the dose (D and BED). Here, FOLH1 is linked to neoplasm.